The latest updates on our research and how it is improving people’s lives.
Liposomal bupivacaine found to be no more effective than current treatments for post-operative knee pain
6 April 2022
A new study published in JAMA, has found that a drug recently licensed in the UK has no effect on post-operative knee replacement recovery or pain, compared to the current treatment when administered at site of surgery.
New research suggests targeting blood vessels could be key to controlling fibrotic disease
1 April 2022
By studying blood vessels at single cell resolution, Professor Jagdeep Nanchahal and colleagues found that in Dupuytren’s disease, a fibrotic disorder of the hand, the vasculature is key to orchestrating the development of human fibrosis.
AI helps to detect bone fractures to 92% accuracy
31 March 2022
Research from the Botnar Institute for Musculoskeletal Sciences shows that Artificial intelligence (AI) is an effective tool for fracture detection that has potential to aid clinicians in busy emergency departments.
Defining the role of resident memory B cells in the fight against influenza
31 March 2022
Researchers at the Kennedy Institute of Rheumatology have used 3D and live-imaging to show how resident memory B cells boost antibodies to fight influenza.
A blood atlas of COVID-19 defines hallmarks of disease severity and specificity
23 March 2022
The COVID-19 Multi-omic Blood Atlas (COMBAT) has identified blood hallmarks of COVID-19 involving particular immune cell populations and their development, components of innate and adaptive immunity, and connectivity with the inflammatory response.
No link found between COVID-19 vaccines and neurological events
16 March 2022
But researchers find an increased risk for unvaccinated people infected with SARS-CoV-2.
Professor David Beard named NIHR Senior Investigator
16 March 2022
NDORMS Professor of Musculoskeletal and Surgical Science, David Beard, has been named National Institute of Health Research (NIHR) Senior Investigator.
Oxford researchers awarded funding to study the immune response to malaria
15 March 2022
Professors Matthew Higgins and Michael Dustin from the University of Oxford, Prof Gavin Wright from the University of York, and Professors Shiroh Iwanaga and Hisashi Arase from Osaka University have secured a Wellcome Collaborative Award for their study “How do RIFINs and STEVORs modulate human immunity during malaria?”
Oxford leads global cross-collaboration Covid research
14 March 2022
A new collaboration between Oxford, Brazil and Pakistan has been funded by the Bill & Melinda Gates Foundation. The partnership will provide researchers with de-identified health data from two of the worlds global COVID-19 hotspots to increase understanding of COVID-19 in these communities and help accelerate the management of the disease.
Study reveals that bone changes the energy requirements of cancer cells to promote growth and survival
11 March 2022
Interrogating metabolic crosstalk in the tumour-bone microenvironment, new research from the Edwards group shows how the pentose phosphate pathway contributes to prostate cancer bone metastasis.
Family raises money for Psoriatic Arthritis research in Oxford
10 March 2022
The family of Terry Barber visited the Botnar Institute for Musculoskeletal Sciences today to present a cheque for £350 in his memory.
Funding boost for early-stage clinical research
8 March 2022
Oxford is one of 28 sites that will benefit from over £160 million awarded over five years to expand early phase clinical research for the benefit of NHS patients.
New funding awarded to study persistent pain in inflammatory arthritis
7 March 2022
The £3.9M Wellcome Collaborative Award will be used to identify the drivers of pain in people living with rheumatoid arthritis.
Two new initiatives launched to support staff and student wellbeing
23 February 2022
People are at the heart of NDORMS and as such the department is dedicated to fostering an inclusive and supportive culture for all its staff and students. Two new initiatives have been recently launched; the mediation service, and a mental health first aiders programme.
Professor Jonathan Rees appointed as new Head of Department at NDORMS
14 February 2022
Prof Jonathan Rees will take up the leadership role on 1 April.
NDORMS joins DARWIN EU® Coordination Centre for drug and vaccine safety
11 February 2022
The European Medicines Agency has announced the establishment of the Data Analysis and Real World Interrogation Network (DARWIN EU®) to support better decision making on the development and effectiveness of medicines and vaccines.
Cemented hip replacement improves quality of life for patients over 60
10 February 2022
The White 5 trial compared implants fixed with bone cement against uncemented implants for hip fractures treated with hemiarthroplasty.
Kassim Javaid awarded new funding for pioneering osteoporosis research
7 February 2022
Kassim Javaid has been announced as one the successful applicants of The Royal Osteoporosis Society’s largest ever research grants round.
NDORMS professors join Global Scholars Program
7 February 2022
Professors Stephanie Dakin and Paul Bowness have been announced as 2021 recipients of the Novartis Institutes for BioMedical Research (NIBR) Global Scholars Program (NGSP).
The Duchess of Cornwall opens the new Marcela Botnar wing
26 January 2022
A new building at the University of Oxford's Botnar Institute for Musculoskeletal Sciences has been opened by The Duchess of Cornwall.